Emerging Agents in the Pipeline for Merkel Cell Carcinoma

2 意见
administrator
administrator
07/17/23

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个